AFC-203CL

antibody from Creative Biolabs

Targeting: DLK1 Delta1, FA1, pG2, Pref-1, ZOG

No application information provided.

Antibody Data

Product number

AFC-203CL

Provider

Creative Biolabs

Product name

Afuco? Anti-Human DLK1 ADCC Therapeutic Antibody (LIV-1205), ADCC Enhanced

Antibody type

Monoclonal

Description

Anti-DLK1 ADCC Enhanced Antibody (LIV-1205) is an ADCC enhanced antibody produced by our Afuco? platform. LIV-1205 is a humanized monoclonal antibody targeting cell surface antigen "DLK-1 (Delta-like 1 homolog)" of liver cancer and other solid cancers. DLK-1 is expected to control the proliferation and differentiation of stem cells, progenitor cells, and other immature cells. LIV-1205 have shown potent anti-tumor activity in various cancer models and is expected to have beneficial clinical efficacy.

Reactivity

Human

Storage

Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles.